UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042971
Receipt number R000047823
Scientific Title The impact of reverse triggering on achieving low tidal volume for patients with respiratory failure
Date of disclosure of the study information 2021/01/11
Last modified on 2023/03/28 20:56:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The impact of reverse triggering on achieving low tidal volume for patients with respiratory failure

Acronym

The impact of reverse triggering on achieving low tidal volume for patients with respiratory failure

Scientific Title

The impact of reverse triggering on achieving low tidal volume for patients with respiratory failure

Scientific Title:Acronym

The impact of reverse triggering on achieving low tidal volume for patients with respiratory failure

Region

Japan


Condition

Condition

acute respiratory failure, ARDS

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Lung-protective mechanical ventilation with the use of lower tidal volumes is beneficial for patients with ARDS and without ARDS. However, there is little evidence about a specific amount of tidal volume less than 10ml/kg/PBW. Achieving 6ml/kg/PBW of tidal volume without neuromuscular blockade is sometimes interrupted by the patients-ventilator asynchrony (PVA).
PVA is defined as a mismatch between the patient breathing efforts with a ventilator's breath delivery. A higher incidence of PVA is significantly related to ICU mortality. Reverse triggering (RT) is one of the types of PVA, which is defined as the inspiratory effort due to the mandatory breathe by a mechanical ventilator. RT is a notable phenomenon because the incidence of RT is almost fifty percent of mechanically ventilated ARDS patients and RT may exacerbate the lung injury. Lower tidal volume may also relate to the incidence of RT according to a prospective multicenter observational study.
Therefore, this study aims to investigate the incidence of RT in mechanically ventilated patients receiving 6ml/kg/PBW compared to 7.5 ml/kg/PBW.

Basic objectives2

Others

Basic objectives -Others

This study aims to clarify the incidence of RT in mechanically ventilated patients with acute respiratory failure (PaO2/FIO2 < 300mmHg) including ARDS, comparing 6 ml/kg PBW of tidal volume with 7.5 ml/kg PBW.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of reverse triggering [Time frame: during 45 minutes]

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Tidal volume 6 ml/kg (Predicted Body Weight) [Time frame: during 15 minutes]

Interventions/Control_2

Tidal volume 7.5 ml/kg (Predicted Body Weight) [Time frame: during 15 minutes]

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Age > 20 years old, <85 years old
Acute respiratory failure and ARDS (PaO2/FIO2 < 300mmHg)
Those who can obtain written consent from the substitute for participation in this study
Receiving intubation within 72 hours
Being expected to receive mechanical ventilation at least 72 hours.

Key exclusion criteria

Receiving neuromuscular blockage
brain death
bronchoalveolar fistula
post esophageal cancer surgery
contraindication to Edi catheter insertion (Esophageal varices and perforation)
using ECMO (extracorporeal membrane oxygenation)
mechanical ventilation due to asthma and COPD
hemodynamic instability
pregnant patient
Those who are deemed inappropriate by the principal investigator or research co-investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Nobuaki
Middle name
Last name Shime

Organization

Hiroshima University

Division name

Department of Emergency and Critical Care Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5456

Email

nshime@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Tatsutoshi
Middle name
Last name Shimatani

Organization

Hiroshima University

Division name

Department of Emergency and Critical Care Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5456

Homepage URL


Email

tatsutoc@gmail.com


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Hiroshima University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8551

Tel

0822571551

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2020 Year 09 Month 29 Day

Date of IRB

2020 Year 12 Month 23 Day

Anticipated trial start date

2021 Year 01 Month 11 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 11 Day

Last modified on

2023 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047823